ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MXF Medicx Fund

96.40
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medicx Fund LSE:MXF London Ordinary Share GG00B1DVQL92 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 96.40 95.80 96.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

The MedicX Fund Limited Issue of ordinary shares (5973E)

09/05/2017 10:13am

UK Regulatory


Medicx (LSE:MXF)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Medicx Charts.

TIDMMXF

RNS Number : 5973E

The MedicX Fund Limited

09 May 2017

For immediate release

9 May 2017

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Issue of ordinary shares

MedicX Fund Limited announces that earlier today, Tuesday 9 May 2017, it issued for cash 1,850,000 ordinary shares of no par value in the Company. The ordinary shares were issued under the Company's block listing facility, at a price of 88.75 pence per share.

The net proceeds raised will be used in further pursuing the investment objectives of the Company.

Total voting rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares in the capital of the Company in issue following this transaction will be 426,114,107 (excluding treasury shares) each with one voting right.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

The Company also holds 7,619,893 ordinary shares in treasury and has 2,268,399 ordinary shares of no par value remaining under its block listing facility to be used to satisfy demand that cannot be met through the secondary market.

- End -

For further information please contact:

   MedicX Fund                                                                  +44 (0) 1481 723 450 

David Staples, Chairman

   Octopus Healthcare Group                                               +44 (0) 20 3142 4820 

Mike Adams, Chief Executive Officer

   Canaccord Genuity                                                          +44 (0) 20 7523 8000 

Andrew Zychowski/Helen Goldsmith

   Buchanan                                                                      +44 (0) 20 7466 5000 

Charles Ryland/Victoria Hayns

Information on MedicX Fund Limited

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 156 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP6 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOESSFSUUFWSEFI

(END) Dow Jones Newswires

May 09, 2017 05:13 ET (09:13 GMT)

1 Year Medicx Chart

1 Year Medicx Chart

1 Month Medicx Chart

1 Month Medicx Chart

Your Recent History

Delayed Upgrade Clock